Christopher McNulty has been appointed to an expanded role as vice president of investor relations and corporate communications at InVivo Therapeutics, in addition to his position as vice president of business development. Mr. McNulty will lead an integrated corporate communications effort for its strategic focus on developing therapies for spinal cord injury that will include investor relations, public relations, medical/scientific communications, patient advocacy, and the spinal cord injury (S...